{"id":"W2153867442","doi":"10.1056/nejmoa066838","title":"Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3647,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Tolerability; Interferon alfa; Oncology; Interferon; Internal medicine; Cancer research; Alpha interferon; Discovery and development of mTOR inhibitors; Pharmacology; Immunology; Adverse effect; PI3K/AKT/mTOR pathway; Apoptosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}